Skeletal muscle expression and abnormal function of beta-myosin in hypertrophic cardiomyopathy

G Cuda1, L Fananapazir, W S Zhu

  • 1Laboratory of Molecular Cardiology, National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, Maryland 20892.

Insights

Genetic mutations in the beta-myosin heavy chain (beta-MHC) gene cause hypertrophic cardiomyopathy. These mutations lead to abnormal protein interactions in muscle, affecting function.

Area of Science:

  • Cardiovascular Genetics
  • Molecular Cardiology
  • Inherited Cardiomyopathies

Background:

  • Hypertrophic cardiomyopathy (HCM) is a significant inherited cardiac condition.
  • The beta-myosin heavy chain (beta-MHC) gene is implicated in some HCM cases.
  • Understanding the molecular basis of HCM is crucial for diagnosis and treatment.

Purpose of the Study:

  • To investigate the expression of mutant beta-MHC gene in skeletal muscle of HCM patients.
  • To determine the functional consequences of beta-MHC gene mutations on myosin function.
  • To confirm the role of missense mutations in the beta-MHC gene in HCM etiology.

Main Methods:

  • Utilized missense and silent mutations in the beta-MHC gene as genetic markers.
  • Demonstrated the presence of mutant and normal cardiac beta-MHC gene message in skeletal muscle.
  • Performed Western blot analysis to detect mutant beta-myosin in skeletal muscle.
  • Conducted in vitro motility assays to assess actin filament translocation by mutant beta-myosin.

Main Results:

  • Mutant beta-MHC gene message was detected in the skeletal muscle of HCM patients.
  • Mutant beta-myosin protein was confirmed to be present in skeletal muscle.
  • Mutant beta-myosin exhibited slower translocation of actin filaments compared to normal controls in vitro.
  • Identified abnormal actomyosin interactions due to single amino acid changes in beta-myosin.

Conclusions:

  • Missense mutations in the beta-MHC gene are a primary cause of hypertrophic cardiomyopathy.
  • Specific amino acid alterations in beta-myosin lead to dysfunctional actomyosin interactions.
  • Skeletal muscle expression of mutant beta-MHC provides insights into HCM pathogenesis.

Related Concept Videos

Structure of Cardiac Muscles01:13

Structure of Cardiac Muscles

Cardiac muscle, or myocardium, is a specialized type of muscle found exclusively in the heart. Its unique structural and functional characteristics enable the heart to perform its vital role of pumping blood throughout the body continuously and rhythmically. The cardiac muscle cells, or cardiomyocytes, possess an endomysium and perimysium but do not have an epimysium.
Compared to skeletal muscles, cardiac muscle cells are small and mostly have a single nucleus. Additionally, they are usually...
Specialized Characteristics of Cardiac Muscles01:27

Specialized Characteristics of Cardiac Muscles

The primary role of cardiac muscles is to propel blood throughout the cardiovascular system. The cardiac muscle cells, or cardiomyocytes, exhibit specialized characteristics that allow them to perform this function.
Cardiac muscle cells are smaller than skeletal muscles, averaging 10–20 mm in diameter and 50–100 mm in length. However, they have large energy demands for continuous contraction and relaxation. This energy is almost exclusively derived from aerobic metabolism of energy reserves in...
Myocarditis I: Introduction01:21

Myocarditis I: Introduction

Myocarditis is inflammation of the myocardium, which is the muscular layer of the heart.EtiologyMyocarditis has a diverse etiology, including a wide range of infectious and non-infectious causes:Infectious CausesViral: Common viruses include Coxsackie A and B, adenovirus, parvovirus B19, enteroviruses, and influenza A.Bacterial: Examples include infections caused by Streptococcus, Staphylococcus, and Mycoplasma species.Rickettsial: Infections like Rocky Mountain spotted fever can result in...
Cardiomyopathy I: Introduction and Classification01:25

Cardiomyopathy I: Introduction and Classification

Cardiomyopathy, or CMP, is a group of diseases affecting the myocardial structure, impairing its ability to pump blood effectively. This condition can lead to arrhythmias, heart failure, or sudden cardiac death.Cardiomyopathies are classified into primary and secondary categories:Primary Cardiomyopathy refers to conditions involving only the heart muscle that are often idiopathic (of unknown cause) or genetic. They primarily affect the myocardium without the involvement of other systemic...
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...